Topics
March 2012 | Perspectives: from The Editors Of New Retina Md
The Sunshine Act's Intimidation Factor
Will the noble objectives of this law set up a roadblock to innovation?
Richard S. Kaiser, MD, and Jonathan L. Prenner, MD
October 7, 2026
Atsena Reports Preliminary ATSN-201 Results in X-linked Retinoschisis
Study Links GLP-1 Use to Earlier Fellow-Eye NAION Involvement
Volk Optical Launches ClearField Pro Lens for Retinal Examination and Laser Treatment
October 6, 2026
2026 Nobel Prize in Medicine Recognizes Optogenetics Pioneers
September 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
September 2026 Supplement
Content Sponsored by Apellis, A subsidiary of Biogen
Editorially independent content supported with advertising by Eyepoint
This activity is supported by an independent educational grant from AlconVision, LLC
View Program
This program will open on EvolveMedEd.com.
Free Print Subscription
Email Newsletter
Conference Calendar
